NEWS is proud to be able to offer Genomic Testing in our office! This is exciting 21st Century Medicine!

Genomic testing is now offered at NEWS.........Genovations is the advent of truly personalized healthcare. 

By harnessing the ingenuity of new breakthroughs in genomic science with the power of preventive biomedicine, Genovations offers an innovative, advanced health care model for more effectively preventing and treating chronic disease.

Our predictive genomic profiles assess genetic variations in each person that, when combined with modifiable factors in the environment, may increase disease risk. This empowers physicians and patients to realize:

Earlier, more effective preventive interventions-years before disease develops
Precise, customized therapies that truly address each individual's needs
Improved clinical insight into patients with treatment-resistant "chronic" conditions

Genovations - Profiles Available:

CardioGenomic® Profile - Identifies genetic single nucleotide polymorphisms associated with increased risk of developing atherosclerosis, hypertension, and coronary artery disease. Risk factors include methylation defects, hyper-coagulation syndromes, cholesterol regulation defects, inflammation, general risk markers and cardio-protective markers.

CardioGenomicPlus™ Profile - This test evaluates genetic variations, called single nucleotide polymorphisms (SNPs), in genes that modulate blood pressure regulation, lipid balance, nutrient metabolism, inflammation, and oxidative stress.

Comprehensive Inflammation Panel - This test is a comprehensive genotypic-phenotypic assessment to evaluate genomic risk of inflammation, as well as current expression of inflammation. The interrelationship of genes and environmental influence leads to unique phenotypic expression for each individual.

DetoxiGenomic® Profile - Identifies genetic single nucleotide polymorphisms associated with increased risk of developing detoxification defects especially with increased exposure to xenobiotics and other toxins. Risk factors include altered cytochrome P-450 activity in phase 1 detoxification, impaired glutathione conjugation and acetylation in phase 2 reactions, altered catecholamine methylation and increased oxidative stress. Detoxification defects have been associated with increased risk for certain cancers, chronic fatigue, multiple chemical sensitivity, and alcoholism

EstroGenomic™ Profile - This test evaluates genetic variations, called single nucleotide polymorphisms (SNPs), in genes that modulate estrogen metabolism, coagulation, cardiovascular disease, and osteoporosis.

ImmunoGenomic® Profile - Identifies genetic single nucleotide polymorphisms associated with increased risk of developing defects in immune competence and surveillance. Risk factors include altered interleukin production and activity within the body and increased production of other cytokines like tissue necrosis factor alpha that may lead to conditions characterized by chronically up-regulated inflammatory response. Immunologic polymorphisms have been associated with increased risk of asthma, atopy, osteopenia, heart disease, and infectious diseases.

NeuroGenomic™ Profile - This test evaluates single nucleotide polymorphisms (SNPs) in genes that modulate methylation, glutathione conjugation, oxidative protection and the potential to evaluate vascular oxidation.

OsteoGenomic® Profile - Identifies genetic single nucleotide polymorphisms associated with increased risk of developing osteopenia and osteoporosis. Risk factors include collagen synthesis, calcium metabolism, vitamin D3 activity, parathyroid hormone action, osteoclastic activity, and chronic inflammation.

Click here to make an appointment with the physicians at NEWS to discuss
the use of Genovations in your healthcare!
2002 Genovations, a product of Great Smokies Diagnostic Laboratory